glp-1 and suicidal ideation U.S. FDA finds no evidence yet linking weight-loss drugs to thoughts MHRA finds evidence does not

The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy

The STEP 4 trial showed that patients who continued semaglutide maintained 80% of their weight loss over 2 years, while those switched to placebo regained weight rapidly

This is usually less than 1.5 milliliters (mL), but up to 3 mL may be administered into the abdomen

Unlike semaglutide and tirzepatide (which could be compounded during shortages), retatrutide has never been FDA-approved

Stabilizing hormones during this transitional period can help maintain consistent GLP-1 responses

Well go into these more in-depth later, but these three things appeared to help: Exercise: Studies show that getting regular exercise can help keep the weight off a year after stopping